Does Ativan (lorazepam) help with akathisia caused by risperidone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Ativan Help with Akathisia Due to Risperdal?

Yes, lorazepam (Ativan) can help manage akathisia caused by risperidone (Risperdal), though it is not the first-line treatment. The most recent APA guidelines recommend considering benzodiazepines as one of several options for antipsychotic-induced akathisia 1.

Treatment Algorithm for Risperidone-Induced Akathisia

First-Line Approaches

The optimal initial strategy is to lower the risperidone dose or switch to another antipsychotic with lower akathisia risk (such as quetiapine or olanzapine) 2, 1. The 2020 APA guidelines specifically suggest three options for akathisia: lowering the antipsychotic dose, switching to another agent, or adding adjunctive medication 1.

When to Use Lorazepam

If dose reduction or switching is not clinically feasible (e.g., psychotic symptoms are well-controlled and you cannot risk destabilization), lorazepam becomes a reasonable adjunctive option 1. The APA guidelines list benzodiazepines alongside beta-blockers as acceptable add-on treatments for akathisia 1.

Evidence Supporting Lorazepam for Akathisia

The evidence base is modest but supportive:

  • A 1987 open trial showed marked improvement in 9 of 16 patients with neuroleptic-induced akathisia treated with lorazepam, with statistically significant reductions in akathisia scores from 1.81 at baseline to 0.32 after 14 days 3.

  • One case report documented successful management of olanzapine-induced akathisia when the drug was reintroduced in combination with lorazepam after initial akathisia resolution 4.

  • A 2021 case report noted that lorazepam was attempted (though ultimately unsuccessful) for lithium-induced akathisia in a patient also on risperidone 5, suggesting it is commonly used in clinical practice.

Practical Dosing Considerations

While specific dosing for akathisia is not well-established in guidelines, typical starting doses would be lorazepam 0.5-2 mg as needed, based on its use in agitation management 6. The FDA label for risperidone confirms that akathisia occurs in 8-10% of adult patients on risperidone 7.

Alternative and Preferred Options

Beta-blockers (particularly propranolol 10-30 mg two to three times daily) have stronger evidence as first-line pharmacologic treatment for akathisia 2, 1. A 2021 review using the mnemonic "B-CALM" (Beta-blockers, Clonazepam, Anticholinergics, cLonidine, Mirtazapine) noted that current evidence best supports propranolol and mirtazapine 8.

Important Caveats

  • Anticholinergic agents are generally NOT helpful for akathisia (unlike other extrapyramidal symptoms like dystonia or parkinsonism) 9, 1.

  • Benzodiazepines carry risks of tolerance, dependence, cognitive impairment, and paradoxical agitation (occurring in ~10% of patients) 10, so they should be used judiciously and for the shortest duration necessary.

  • Akathisia is frequently misdiagnosed as psychotic agitation or anxiety 9, which can lead to inappropriate dose escalation of the offending antipsychotic—worsening the problem. Careful assessment is critical.

Bottom Line

Lorazepam can provide symptomatic relief for risperidone-induced akathisia when dose reduction or switching is not possible, but beta-blockers like propranolol should be considered first-line pharmacologic treatment. The combination approach of continuing risperidone with adjunctive lorazepam has documented success 4, making it a viable strategy when maintaining antipsychotic efficacy is paramount.

Related Questions

In a patient receiving intramuscular zuclopenthixol decanoate (Clopixol Depot) 200 mg/mL every two weeks who develops akathisia despite biperiden (Akineton) 4 mg, what is the appropriate treatment?
A patient on Geodon (ziprasidone) 40 mg in the morning and 60 mg at bedtime has akathisia; can the medication be stopped abruptly and switched to olanzapine?
Will drug‑induced akathisia improve after discontinuing olanzapine?
How should akathisia induced by Latuda (lurasidone) be managed, and what are the recommended medications for bipolar disorder?
How should akathisia associated with Vraylar (cariprazine) be managed?
What is the appropriate starting dose, titration schedule, and taper plan for sertraline in a 55-year-old male with major depressive disorder?
Is Ozempic (semaglutide) administered as a subcutaneous injection appropriate for a patient with Down syndrome who is taking metformin 1000 mg twice daily and glipizide 5 mg, with an HbA1c of 7.1%?
What is the probability that a 17‑mm mediastinal lymph node in a heavy smoker is malignant rather than reactive?
What are the indications, pre‑operative assessment, surgical technique, postoperative care, and expected outcomes for release of a flexion contracture (sitter’s contracture) with first (thumb) and fifth (little finger) tendon release in the hand?
How should I manage a 3-year-old girl who had bacterial conjunctivitis yesterday and now presents with yellow‑brown, malodorous vaginal discharge and vaginal discomfort?
What is the recommended management for Dupuytren's contracture involving the thumb (first web) and little finger?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.